✦ LIBER ✦

Phase I/II trial of cisplatin (CDDP), etoposide (ETP), and irinotecan (CPT-11) for the treatment of advanced non-small-cell lung cancer (NSCLC). Japan Clinical Oncology Group (JCOG) study 9512

✍ Scribed by Makino, M; Tsukada, H; Yokoyama, A; Kurita, Y; Isobe, H; Watanabe, K; Saijo, N

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of irinotecan (CPT-11) and

✍ Nakamura, Y; Fukuda, M; Fukuda, Mi; Soda, H; Ichiki, M; Takatani, H; Kanda, T; K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Phase I study of irinotecan (CPT-11), ci

✍ Langer, C; Movsas, B; Huang, C; Millenson, M; Maiale, C; Donahue, J; Treat, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

The final results of a randomized phase

✍ Takiguchi, Y; Nagao, K; Nishiwaki, Y; Yokoyama, A; Saijo, N; Ohashi, Y; Niitani, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Phase II multi-institutional study of Ir

✍ Cardenal, F.; Domine, M.; Massuti, B.; Felip, E.; Carrato, A.; Garrido, P.; Albe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Phase II trial of postoperative adjuvant

✍ Ryosuke Tsuchiya; Kenji Suzuki; Yukito Ichinose; Yoh Watanabe; Tsutomu Yasumitsu 📂 Article 📅 2005 🏛 CTSNet 🌐 English ⚖ 202 KB

Fractionated administration of cisplatin

✍ Takata, I; Ueoka, H; Kiura, K; Hiraki, S; Eguchi, K; Okimoto, N; Harita, S; Yone 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB